Creative Planning
RCUS icon

Creative Planning’s Arcus Biosciences RCUS Stock Holding History

Creative Planning’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$966K Sell
31,342
-2,103
-6% -$52K ﹤0.01% 2663
2026
Q1 		$722K Buy
33,445
+2,073
+7% +$44.8K ﹤0.01% 2735
2025
Q4 		$748K Buy
31,372
+1,743
+6% +$35.6K ﹤0.01% 2507
2025
Q3 		$403K Buy
29,629
+771
+3% +$8.02K ﹤0.01% 2917
2025
Q2 		$235K Buy
+28,858
New +$246K ﹤0.01% 3101
2025
Q1 		– Sell
-79
Closed -$1.18K – 3677
2024
Q4 		$1.18K Buy
+79
New +$1.29K ﹤0.01% 3514

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Creative Planning's RCUS Position: Q2 2026 in Review

Creative Planning reduced its Arcus Biosciences (RCUS) stake by 6.3% in Q2 2026, selling an estimated $52K and leaving 31,342 shares worth $966K. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

Creative Planning first reported a position in RCUS in Q4 2024 and has held it in 6 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Creative Planning held 31,342 shares of Arcus Biosciences worth $966K as of Q2 2026.
  • Creative Planning sold 2,103 Arcus Biosciences shares in Q2 2026, an estimated $52K.
  • Arcus Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2663 holding.
  • Creative Planning first reported a position in Arcus Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.